Reviewed clinical summary · Source-linked · Educational use only

Low-Calorie Diets Achieve Type 2 Diabetes Remission in Chinese Adults Comparable to Other Populations

Clinical Bottom Line

Summary: In Chinese adults with type 2 diabetes, a 6-month low-calorie diet achieved diabetes remission in 56% of participants, with formula-based and real food-based diets performing equally well and notable individual variability in response. PICO Summary Element Detail Population Chinese adults with…

Summary: In Chinese adults with type 2 diabetes, a 6-month low-calorie diet achieved diabetes remission in 56% of participants, with formula-based and real food-based diets performing equally well and notable individual variability in response.

PICO Summary

ElementDetail
PopulationChinese adults with type 2 diabetes (BMI 24–45 kg/m², HbA1c 6.5–12.0%); n=41.
InterventionLow-calorie diet, 815–835 kcal/day for 3 months then a 3-month maintenance phase; formula-based (LCFD, n=21) and real food-based (LCRFD, n=20) variants. All anti-diabetic drugs stopped on day 1.
ComparisonLCFD versus LCRFD head-to-head; remission rates also benchmarked against published data from other populations.
Outcome56.1% achieved T2D remission at 6 months; 39.0% lost ≥10% body weight. Significant reductions in liver and pancreatic fat. No difference between LCFD and LCRFD. Nonresponders had longer duration, poorer control, and lower beta-cell function.

Expert Commentary

I have watched the remission story unfold largely through a Western lens, and a quiet worry has sat at the back of my mind that the DiRECT findings might not transfer to my leaner Asian patients, whose diabetes often looks more like beta-cell failure than pure insulin resistance. This study is reassuring precisely because it addresses that worry directly, and a remission rate of 56% in Chinese adults is not a watered-down version of the Western result, it is comparable. What I find genuinely useful is that formula and ordinary food worked equally well, because it means I can shape a programme around what a patient will actually stick to rather than insisting on meal-replacement products. The honest limitation is the size, just 41 patients, and the lack of long-term durability data, so I am cautious about promising my patients that remission will last. Can I use this with my patients? Yes, and with more confidence in my Chinese and other Asian patients than I had a year ago, particularly those with shorter-duration disease and preserved beta-cell function. I would now like to see the durability data that tells me how many are still in remission at two years.

References

Liu Z, Feng N, Wang S, et al. Low-calorie diets and remission of type 2 diabetes in Chinese: phenotypic changes and individual variability. Nutr J. 2025;24(1):42. doi:10.1186/s12937-025-01101-z

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.